Ramiro Martin Cabral
CIK 1752437 · SEE REMARKS · last filed 2026-03-05
Ramiro Martin Cabral is a corporate insider who has filed 23 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider had shares withheld for taxes covering $161.5K of ELAN on Mar 5, 2026. Across all open-market trades the lifetime net is +$24.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $7.7M across reported positions. 24 SEC filings were submitted jointly with Elanco Animal Health Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ELAN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
GREENFIELD, IN 46140
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELAN | SEE REMARKS | 283,874 | $27.12 | $7.70M | $24.0K | 15 | 2026-03-05 |
| Elanco Animal Health Inc (ELAT) Delisted | SEE REMARKS | 82,941 | $21.32 | $1.77M | $0 | 8 | 2022-03-03 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-05 | ELAN | Tax (F) | −6,492 | -$161.5K | EDGAR |
| 2026-03-03 | ELAN | Mixed | +50,737 | -$796.0K | EDGAR |
| 2025-03-05 | ELAN | Grant (A) | +44,209 | $0 | EDGAR |
| 2025-03-04 | ELAN | Tax (F) | −11,749 | -$131.2K | EDGAR |
| 2025-02-21 | ELAN | Mixed | +38,121 | -$338.2K | EDGAR |
| 2024-03-05 | ELAN | Mixed | +19,398 | -$142.8K | EDGAR |
| 2024-02-29 | ELAN | Mixed | +11,803 | -$157.0K | EDGAR |
| 2023-03-06 | ELAN | Mixed | +22,806 | -$194.0K | EDGAR |
| 2023-03-03 | ELAN | Mixed | +32,985 | -$53.3K | EDGAR |
| 2022-03-03 | Elanco Animal Health Inc (ELAT) Delisted | Mixed | +9,556 | -$91.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.